课题基金 / 基金详情

Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor

Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
己烯雌酚和甲氧滴滴涕的产前发育免疫毒性
批准号:
8267799
负责人:
Christine Ann Broussard
金额:
$0.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2013-06-30

项目摘要

项目成果

Christine Ann Broussard的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):内分泌干扰物(EDCs)存在于整个环境中,从废水到塑料中的添加剂,再到粮食作物上使用的杀虫剂。越来越多的证据表明,内分泌细胞不仅影响生殖健康和癌症发病率,而且还影响免疫健康。例如,产前暴露于各种EDC的儿童传染病发病率增加,并在受到挑战时采取次优疫苗接种反应。此外,在子宫内暴露于己烯雌酚(一种已知会导致生殖癌的模型雌激素)的女性显示出自身免疫性疾病和感染性疾病的增加。此外,过敏性疾病和哮喘在过去几十年里有所增加,特别是在儿童中。由于时间的限制,免疫性疾病的快速上升不能归因于遗传因素。普遍的共识是,环境暴露,特别是在胎儿发育期间,可能是免疫性疾病发展的一个重要因素。尽管越来越多的证据支持EDC在免疫系统发育中的负面作用,但关键问题仍然存在。在什么阶段和剂量下,人类最容易受到内分泌干扰物的免疫影响?研究表明,发育中的免疫系统(在怀孕期间)特别脆弱,而且比成人免疫系统更脆弱。我们假设己烯雌酚和甲氧氯胺(两种已建立的内分泌细胞)在产前免疫系统发育过程中存在时会改变T细胞的分化,最终导致不适当的免疫抑制或激活。利用体外胎儿期T细胞分化试验,本研究中的实验将确定DES和MXC是否能够在低剂量下改变胚胎发育期间的免疫系统,2)通过抑制发育来调节它们的作用,或3)通过诱导细胞凋亡来调节它们的作用。对DES和MXC的分阶段分析将增强我们对这些内分泌干扰物如何以及何时影响免疫系统的理解,并将形成评估其他EDC的产前免疫毒性和预防妊娠EDC暴露引起的免疫疾病的策略的基础。与公共健康相关:从废水排放(如个人护理产品和药品)到塑料添加剂(如双酚A)再到粮食作物上使用的杀虫剂(如阿特拉津),环境中都存在内分泌干扰物(EDCs)。越来越多的证据表明,内分泌细胞对免疫系统产生负面影响,可能导致免疫疾病,如哮喘、过敏、自身免疫性疾病、反复耳部感染和疫苗反应不良,特别是在儿童中。拟议的研究将加强我们对内分泌细胞如何以及何时影响免疫系统的了解,并将形成评估内分泌细胞对产前免疫影响的基础,以及预防产前接触内分泌细胞引起的免疫疾病的策略。
英文摘要
DESCRIPTION (provided by applicant): Endocrine-disrupting chemicals (EDCs) are present throughout the environment, from wastewater effluent to additives in plastic to pesticides used on food crops. Growing evidence suggests that EDCs not only influence reproductive fitness and cancer incidence, but also immune fitness. For example, children exposed prenatally to a variety of EDCs had an increased incidence of infectious diseases and mounted a suboptimal vaccination response when challenged. Furthermore, women exposed in utero to diethylstilbestrol (a model estrogen known to cause reproductive cancers) showed an increase in autoimmune and infectious disease. Moreover, allergic diseases and asthma have increased in the past few decades, particularly in children. Because of the time frame, the rapid rise in immune disease cannot be attributed to genetics. The general consensus is that environmental exposures, particularly during fetal development, may be a significant factor in the development of immune disease. Though evidence is mounting that supports a negative role for EDC in immune system development, critical questions remain. At what stage and what doses are humans most vulnerable to the immune impacts of endocrine-disrupting chemicals? Studies have shown that the developing immune system (during gestation) is uniquely vulnerable and more vulnerable than the adult immune system. We hypothesize that diethylstilbestrol and methoxychlor (two established EDCs) alter T cell differentiation when present during prenatal immune system development, ultimately leading to inappropriate immune suppression or activation. Using an in vitro prenatal T cell differentiation assay, the experiments in this proposal will determine whether DES and MXC 1) are capable of altering the immune system during embryological development at low doses, 2) are mediating their effects through inhibition of development, or 3) are mediating their effects through induction of apoptosis. This stage-specific analysis of DES and MXC will enhance our understanding of how and when these endocrine disruptors affect the immune system, and will form the basis for assessment of prenatal immunotoxicity of other EDCs and for strategies to prevent immune disease induced by gestational EDC exposure. PUBLIC HEALTH RELEVANCE: Endocrine-disrupting chemicals (EDCs) are present throughout the environment, from wastewater releases (e.g. personal care products and pharmaceuticals) to additives in plastic (e.g. bisphenol A) to pesticides used on food crops (e.g. atrazine). Growing evidence suggests that EDCs negatively influence the immune system, potentially leading to immune diseases like asthma, allergies, autoimmune disease, repeated ear infections, and poor vaccine responses, particularly in children. The proposed research will enhance our understanding of how and when EDCs affect the immune system, and will form the basis for assessment of prenatal immune impacts of EDCs and for strategies to prevent immune disease caused by prenatal EDC exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
  • 批准号:
    8089807
  • 项目类别:
  • 资助金额:
    $5.73万
  • 财政年份:
    2010
  • 负责人:
    Christine Ann Broussard
  • 依托单位:
Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
  • 批准号:
    8301056
  • 项目类别:
  • 资助金额:
    $5.73万
  • 财政年份:
    2009
  • 负责人:
    Christine Ann Broussard
  • 依托单位:
海外基金